Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model

Journal of Orthopaedic Research

Volumn 30, Issue 5, 2012, Pages 817-823

  Wise Milestone, Lisa ^a   Akens, Margarete K ^a   Rosol, Thomas J ^b   Hojjat, Seyed Parsa ^a   Grynpas, Marc D ^c   Whyne, Cari M ^a  

^a Canada   (Canada)

^b OHIO STATE UNIVERSITY   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

osteolytic osteoblastic; rat model; skeletal metastasis; vertebral bone quality

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE METASTASIS; CANCER CELL; CONTROLLED STUDY; FEMALE; MECHANICAL TORSION; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST ACTIVITY; OSTEOID; OSTEOLYSIS; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RAT; SPINE METASTASIS; TRABECULAR BONE; TUMOR VOLUME; VERTEBRA;

ANIMALS; BONE NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; COMPRESSIVE STRENGTH; DOGS; FEMALE; MALE; NEOPLASMS, EXPERIMENTAL; OSTEOBLASTS; OSTEOCLASTS; OSTEOLYSIS; PROSTATIC NEOPLASMS; RATS; RATS, NUDE;

EID: 84858290400     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21577     Document Type: Article

References (34)

1. Wong DA, Fornasier VL, MacNab I,. 1990. Spinal metastases: the obvious, the occult, and the impostors. Spine (PhilaPa 1976) 15 (1): 1-4. (Pubitemid 20102488)
2. Clezardin P, Teti A,. 2007. Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis 24: 599-608. (Pubitemid 50003596)
3. Guise TA, Mohammad KS, Clines G, et al. 2006. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12: 6213s-6216s. (Pubitemid 44703792)
4. Ye L, Kynaston HG, Jiang WG,. 2007. Bone metastasis in prostate cancer: molecular and cellular mechanisms. Int J Mol Med 20: 103-111.
5. Skrinskas T, Clemons M, Freedman O, et al. Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer. Clin Exp Metastasis 2009. 26 (2): 97-103.
6. Henriksen G, Breistol K, Bruland OS, et al. 2002. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model. Cancer Res 62 (11): 3120-3125. (Pubitemid 34605984)
7. Neudert M, Fischer C, Krempien B, et al. 2003. Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterization and in vivo effects of ibandronate on tumour growth. Int J Cancer 107 (3): 468-477. (Pubitemid 37266469)
8. Blomme EA, Dougherty KM, Pienta KJ, et al. 1999. Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein. Prostate 39 (3): 187-197. (Pubitemid 29203406)
9. Rosol TJ, Tannehill-Gregg SH, Corn S, et al. 2004. Animal models of bone metastasis. Cancer Treat Res 118: 47-81.
10. Koutsilieris M,. 1992. PA-III rat prostate adenocarcinoma cells [review]. In Vivo 6: 199-203.
11. Fodstad O, Brogger A, Bruland O, et al. 1986. Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int J Cancer 38: 33-40. (Pubitemid 16056255)
12. Chaffer CL, Dopheide B, McCulloch DR, et al. 2005. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Met 22: 115-125. (Pubitemid 41185849)
13. Hall CL, Bafico A, Dai J, et al. 2005. Prostate cancer cells promote osteoblastic bone metastases through wnts. Cancer Res 65: 7554-7560. (Pubitemid 41297224)
14. LeRoy BE, Thudi NK, Nadella MVP, et al. 2006. New bone formation and osteolysis by a metastatic highly invasive canine prostate carcinoma xenograft. Prostate 66: 1213-1222. (Pubitemid 44175343)
15. Turner CH, Burr DB,. 1993. Basic biomechanical measurements of bone: a tutorial. Bone 14: 595-608. (Pubitemid 23198821)
16. Vashishth D,. 2008. Small animal bone biomechanics. Bone 43: 794-797.
17. Won E, Wise-Milestone L, Akens MK, et al. 2010. Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumour tissue. Breast Cancer Res Treat 124 (1): 111-119.
18. Akens MK, Hardisty MR, Wilson BC, et al. 2010. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin). Breast Cancer Res Treat 119: 325-333.
19. Hardisty M, Gordon L, Agarwal P, et al. 2007. Quantitative characterization of metastatic disease in the spine. Part I. Semiautomated segmentation using atlas-based deformable registration and the level set method. Med Phys 34 (8): 3127-3134. (Pubitemid 47175776)
20. Hojjat SP, Hardisty MR, Whync CM,. 2010. Micro-computed tomography-based highly automated 3D segmentation of the rat spine for quantitative analysis of metastatic disease. Spine 13 (3): 367-370.
21. Blouin S, Basle MF, Chappard D,. 2005. Rat models of bone metastases. Clin Exp Metastasis 22: 605-614. (Pubitemid 44259521)
22. Power CA, Pwint H, Chan J, et al. 2009. A novel model of bone-metastatic prostate cancer in immunocompetent mice. Prostate 69: 1613-1623.
23. Barengolts EI, Lathon PV, Kukreja SC,. 1996. Effect of various parathyroid hormone-related proteins (PTHrP) fragments on bone resorption and formation in vivo. Bone Miner Res 11 (Suppl 1): S202.
24. Sone T, Tamada T, Jo Y, et al. 2004. Analysis of three-dimensional microarchitecture and degree of mineralization in bone metastases from prostate cancer using synchrotron microcomputed tomography. Bone 35: 432-438. (Pubitemid 38953190)
25. Nakamura H, Hiraga T, Ninomiya T, et al. 2008. Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice. J Bone Miner Metab 26: 642-647.
26. Cody JJ, Rivera AA, Lyons GR, et al. 2010. Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer. Cancer Gene Therapy 17: 893-905.
27. Fritz V, Louis-Plence P, Apparailly F, et al. 2007. Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model. Bone 40: 1032-1040. (Pubitemid 46386549)
28. Lee Y-P, Schwartz EM, Davies M, et al. 2002. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. Cancer Res 62: 5564-5570.
29. Urwin GH, Percival RC, Harris S, et al. 1985. Generalised increase in bone resorption in carcinoma of the prostate. Br J Urol 57: 721.
30. Thudi NK, Martin CK, Nadella MVP, et al. 2008. Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Prostate 68: 1116-1125. (Pubitemid 351875183)
31. Currey JD,. 2003. The many adaptations of bone. J Biomech 36: 1487-1495. (Pubitemid 37117355)
32. Wang X, Li X, Shen X, et al. 2003. Age-related changes of noncalcified collagen in human cortical bone. Ann Biomed Eng 31: 1365-1371.
33. Nazarian A, von Stechow D, Zurakowski D, et al. 2008. Bone volume fraction explains the variation in strength and stiffness of cancellous bone affected by metastatic cancer and osteoporosis. Calcif Tissue Int 83: 368-379.
34. Eswaran SK, Gupta A, Adams MF, et al. 2006. Cortical and trabecular load sharing in the human vertebral body. J Bone Miner Res 21: 307-314. (Pubitemid 43265297)